提供支持According to VCBeat, TreatGut, the first company in China to provide an overall solution for Precision Microbiota Transplantation Therapy (PMTT), has completed its angel round and Pre-A round of financing, bringing the total financing to tens of millions of yuan (US$14 million).
The angel round was led by GIR Medicine Co., Ltd. with participation from Guangzhou Yangpu Bay Innovation Enterprise Incubator Enterprise Co., Ltd. The latest Pre-A round was led by Sunz Fund and jointly invested by Grower Venture Capital. Proceeds of this financing will be used to further improve the PMTT platform, and accelerate the development of micro-ecological drugs.
Founded in 2016, TreatGut is a biological medicine technology company. Its business covers medical diagnosis, micro ecological treatment, micro-ecological drugs, and medical data collection. The company has established the world's first PMTT platform.
Just three years after its establishment, TreatGut has been awarded the "National High-Tech Enterprise" and won the gold medal in the final of the national "Internet +" innovation and entrepreneurship competition in 2019. Based on its PMTT platform, TreatGut expands the indications of microbiota transplantation and develops micro-ecological drugs from the clinical data and multi-omics data, to provide services of disease prevention, diagnosis, treatment, and prognostic assessment, nutritional guidance under the intestinal microecology and achieve overall management of healthy life.
At present, TreatGut has helped many provinces to get the barcode for the expense of microbiota transplantation approved by the National Health Commission and the National Healthcare Security Administration of China. The company has cooperated with hundreds of hospitals, covering 28 provinces and cities in China.
About Sunz Fund
Sunz Fund is one of the first professional institutions to manage the fund invested by the state and local government. It provides personalized investment for high-tech, high-growth SMEs in China. Supported by its financial, medical and industrial resource The company cooperates with many institutions from home and abroad
About Grower Venture Capital
Grower Venture Capital is an industrial fund jointly established by the government of Guangdong province and Tsinghua University. Based on the R&D platform of the Research Institute of Tsinghua, Pearl River Delta, Grower Venture Capital makes full use of its own capital, social capital and government industrial fund, and the advantages of financial and investment systems.
Grower Venture Capital mainly invests in high-end equipment manufacturing (industrial robots, intelligent manufacturing equipment, precision processing, and manufacturing), the transformation and upgrading of traditional industries (Internet with traditional manufacturing, high-end industrial design platform), and some strategic emerging industries (new materials, electronic information, biotechnology).
渝公网安备 50011202502165号
